TherapeuticsMD, Inc. TXMD
1.81 USD +0.01 +0.47%
As of Nov 2, 9:42 AM ET
- YTD
- +10.94%
- 1 year
- +45.84%
- Open
- 1.80
- Prev close
- 1.80
- Mkt cap
- 20.83M
- Vol
- 330
- Avg vol
- 23.65K
- EPS
- -0.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.80
- High
- 1.80
- Forward P/E
- 3.13
- Beta
- 0.00
- Short ratio
- 0.95
- Inst. own
- 44.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.42
- 200-d avg
- 1.79
- 1y target
- 0.00
5D chart
Chart tools
Chart is warming up
The five-day price history for TXMD has not been loaded yet. Try again in a moment.
Altman Z-Score
-34.37 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
P/E -33.1×
P/S 6.2×
P/B 0.7×
P/FCF 7.8×
EV/EBITDA -5.8×
EV/Sales 5.8×
FCF Yield 12.9%
Gross Margin 100.0%
Operating Margin -139.4%
Net Margin -18.8%
ROE -2.1%
ROIC -12.5%
ROA -1.5%
Revenue 71.6%
Operating Income 13.0%
EPS (diluted) 74.1%
Free Cash Flow 231.1%
Current Ratio 3.0×
Quick Ratio 3.0×
Debt / Equity 0.2×
Net Debt / EBITDA 0.5×
Interest Coverage -527×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31